Mitchell Pet

Mitchell Pet

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
PDF file
MPMitchell Pet
Mitchell Pet
JKJason H. Ko
Jason H. Ko
JFJanna L. Friedly
Janna L. Friedly
PMPierre D. Mourad
Pierre D. Mourad
DSDouglas G. Smith
Douglas G. Smith
Symptomatic neuroma occurs in 13% to 32% of amputees, causing pain and limiting or preventing the use of prosthetic devices. Targeted nerve implantation (TNI) is a procedure that seeks to prevent or treat neuroma-related pain in amputees by implanting the proximal amputated nerve stump onto a surgically denervated portion of a nearby muscle at a secondary motor point so that regenerating axons might arborize into the intramuscular motor nerve branches rather than form a neuroma. However, the efficacy of this approach has not been demonstrated. We asked: Does TNI (1) prevent primary neuroma-related pain in the setting of acute traumatic amputation and (2) reduce established neuroma pain in upper- and lower-extremity amputees? We retrospectively reviewed two groups of patients treated by one surgeon: (1) 12 patients who underwent primary TNI for neuroma prevention at the time of acute amputation and (2) 23 patients with established neuromas who underwent neuroma excision with secondary TNI. The primary outcome was the presence or absence of palpation-induced neuroma pain at last followup, based on a review of medical records. The patients presented here represent 71% of those who underwent primary TNI (12 of 17) and 79% of those who underwent neuroma excision with secondary TNI (23 of 29 patients) during the period in question; the others were lost to followup. Minimum followup was 8 months (mean, 22 months; range, 8–60 months) for the primary TNI group and 4 months (mean, 22 months; range, 4–72 months) for the secondary TNI group. At last followup, 11 of 12 patients (92%) after primary TNI and 20 of 23 patients (87%) after secondary TNI were free of palpation-induced neuroma pain. TNI performed either primarily at the time of acute amputation or secondarily for the treatment of established symptomatic neuroma is associated with a low frequency of neuroma-related pain. By providing a distal target for regenerating axons, TNI may offer an effective strategy for the prevention and treatment of neuroma pain in amputees. Level IV, therapeutic study. See Instructions for Authors for a complete description of levels of evidence.

19 April 2024 in Science Advances
Verified
Journal Article
Open access
Shuo LiShuo Li
Shuo Li
DLDi Lu
Di Lu
SLShupeng Li
Shupeng Li
JLJiaqi Liu
Jiaqi Liu
YXYameng Xu
Yameng Xu
JRJohn A. Rogers
John A. Rogers
Continuous monitoring of biomarkers at locations adjacent to targeted internal organs can provide actionable information about postoperative status beyond conventional diagnostic methods. As an example, changes in pH in the intra-abdominal space after gastric surgeries can serve as direct indicators of potentially life-threatening leakage events, in contrast to symptomatic reactions that may delay treatment. Here, we report a bioresorbable, wireless, passive sensor that addresses this clinical need, designed to locally monitor pH for early detection of gastric leakage. A pH-responsive hydrogel serves as a transducer that couples to a mechanically optimized inductor-capacitor circuit for wireless readout. This platform enables real-time monitoring of pH with fast response time (within 1 hour) over a clinically relevant period (up to 7 days) and timely detection of simulated gastric leaks in animal models. These concepts have broad potential applications for temporary sensing of relevant biomarkers during critical risk periods following diverse types of surgeries.

6 March 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
DLDi Lu
Di Lu
SLShupeng Li
Shupeng Li
QYQuansan Yang
Quansan Yang
HAHany M. Arafa
Hany M. Arafa
YXYameng Xu
Yameng Xu
John A. RogersJohn A. Rogers
John A. Rogers

1 May 2019 in Hand Clinics
Verified
Journal Article
Closed access
MPMitchell Pet
Mitchell Pet
JKJason H. Ko
Jason H. Ko

25 October 2024 in Science Advances
Verified
Journal Article
Open access
JCJoanna L. Ciatti
Joanna L. Ciatti
Abraham Vázquez-GuardadoAbraham Vázquez-Guardado
Abraham Vázquez-Guardado
VBVictoria E. Brings
Victoria E. Brings
JPJihun Park
Jihun Park
BRBrian Ruyle
Brian Ruyle
JRJohn A. Rogers
John A. Rogers
Opioid overdose accounts for nearly 75,000 deaths per year in the United States, now a leading cause of mortality among young people aged 18 to 45 years. At overdose levels, opioid-induced respiratory depression becomes fatal without the administration of naloxone within minutes. Currently, overdose survival relies on bystander intervention, requiring a nearby person to find the overdosed individual and have immediate access to naloxone to administer. To circumvent the bystander requirement, we developed the Naloximeter: a class of life-saving implantable devices that autonomously detect and treat overdose while simultaneously contacting first responders. We present three Naloximeter platforms, for fundamental research and clinical translation, all equipped with optical sensors, drug delivery mechanisms, and a supporting ecosystem of technology to counteract opioid-induced respiratory depression. In small and large animal studies, the Naloximeter rescues from otherwise fatal opioid overdose within minutes. This work introduces life-changing, clinically translatable technologies that can broadly benefit a susceptible population recovering from opioid use disorder.

13 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
HSHee-Sup Shin
Hee-Sup Shin
JKJihye Kim
Jihye Kim
NFNicholas Fadell
Nicholas Fadell
LPLogan B. Pewitt
Logan B. Pewitt
YSYusuf Shaaban
Yusuf Shaaban
MPMitchell Pet
Mitchell Pet
Continuous kinematic biofeedback during exercise interventions can lead to improved therapeutic outcomes in hand and wrist rehabilitation. Conventional methods for measuring joint kinematics typically allow only static measurements performed by specially trained therapists. This paper introduces skin-conformal, wearable wireless systems designed to continuously and accurately capture the angles of target joints, specifically in hand and wrist. Supported by a computer vision-based calibration protocol run on a smart device, these magnetometer-based standalone systems provide patients and clinicians with continuous, real-time data on joint angles and ranges of motion through an intuitive graphical interface. Human trials in healthy volunteers demonstrate the accuracy and precision of the electrogoniometry system, as well as its compatibility with simulated hand therapy. We have also demonstrated the electrogoniometry system is suitable for tracking complex and rapid movements and for deployment during occupational tasks where it could serve as a biofeedback device to warn against excessive and clinically contraindicated motion.